43:I[58016,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"ProcessEpisodeButton"] 47:I[45269,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"SignupCTA"] 49:I[56939,["/_next/static/chunks/b5ea50e123aa84a6.js","/_next/static/chunks/050761d0d0bdc5d8.js","/_next/static/chunks/de880ec5a0241b38.js","/_next/static/chunks/48003610e91209eb.js","/_next/static/chunks/15a1b1fbd3cf7d4a.js","/_next/static/chunks/81ce7bf5f20dbd5a.js","/_next/static/chunks/86498082dde169e6.js","/_next/static/chunks/903c358828afe0bc.js","/_next/static/chunks/f63fb02bc4156bfb.js","/_next/static/chunks/88bed98e5cd5e639.js"],"EpisodeTranscript"] 3d:["$","div",null,{"className":"flex flex-col gap-2 text-sm text-muted-foreground","children":[["$","span",null,{"className":"inline-flex items-center gap-2 bg-secondary/50 px-3 py-1 rounded-full","children":[["$","svg",null,{"className":"w-4 h-4","fill":"none","stroke":"currentColor","viewBox":"0 0 24 24","children":["$","path",null,{"strokeLinecap":"round","strokeLinejoin":"round","strokeWidth":2,"d":"M8 7V3m8 4V3m-9 8h10M5 21h14a2 2 0 002-2V7a2 2 0 00-2-2H5a2 2 0 00-2 2v12a2 2 0 002 2z"}]}],["$","time",null,{"dateTime":"2024-11-07T09:15:01.000Z","children":"Thu Nov 07 2024"}]]}],["$","p",null,{"className":"text-base text-foreground/80 leading-relaxed","children":"Brands and retailers are experiencing a shake-up unlike any before, driven not by tech but by the growing use of weight-loss medications like Ozempic and Wegovy. With millions of Americans turning to these GLP-1 medications, supplement stores,..."}]]}] 44:T441,Brands and retailers are experiencing a shake-up unlike any before, driven not by tech but by the growing use of weight-loss medications like Ozempic and Wegovy. With millions of Americans turning to these GLP-1 medications, supplement stores, including GNC and Vitamin Shoppe, are just a small fraction of businesses, racing to tap into the trend.

In this episode, Roxy and Elena explore how retailers are adapting their strategies, from redesigning store layouts to targeting new customer segments. They’ll explore the ripple effects these medications have on consumer behavior, the challenges and opportunities, and what they mean for the future of industries, such as health and wellness, food and beverage, and beyond.

TL;DR

How GNC and Vitamin Shoppe are rethinking their store layouts to appeal to GLP-1 users
The wider industry reaction — from Walmart to Nestlé — to shifting consumer habits
The market potential and concerns around GLP-1 medications and their influence on retail strategies

45:T762,

The Ozempic Craze Is Reshaping Commerce: Here’s How